Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Pharmacokinetics of AB001 Patch in Healthy Subjects
NCT03997734Phase 1Completed
- Sponsor
- Frontier Biotechnologies Inc.
- Start
- Jun 2019
- Primary completion
- Nov 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, single-blind trial of AB001 oral capsule in chronic low back pain (CLBP) (5 arms), sponsored by Frontier Biotechnologies Inc. Primary endpoints: Number of subjects with any adverse events (AEs) at Day 26 and Number of subjects with any serious adverse events (SAEs) at Day 26. Started Jun 2019; status: completed.
02
Drugs
AB001 oral capsule
03
Conditions
chronic low back pain (CLBP)
Beyond the preview
Go deeper on NCT03997734.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03997734.